Generic apixaban tablet tested against eliquis in healthy volunteers
NCT ID NCT06043297
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a generic version of the blood thinner apixaban (5mg tablet) works the same as the brand-name drug Eliquis. Thirty healthy adults took a single dose of each under fasting conditions, and researchers measured drug levels in their blood. The goal was to check if the two products are bioequivalent, meaning they deliver the same amount of medicine into the body.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
apixaban 5mg tablet
What this could lead to
If successful, this could show that the generic apixaban tablet is equivalent to the brand-name drug, potentially offering a more affordable option for patients needing blood thinning.
What could go wrong
This is a small, early-phase study in 30 healthy volunteers, not patients. It only measures drug levels in the blood, not actual health outcomes, so results may not predict real-world effectiveness or safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTITHROMBIC DRUG are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lambda Therapeutic Research Ltd.
Ahmedabad, Gujarat, 382481, India